Learn More
Gibco™ HAT Supplement (50X)

HAT-supplemented medium is suitable for post-fusion selection against unfused or self-fused HGPRT-myeloma cells
Brand: Gibco™ 21060017
Description
- Liquid mixture of sodium hypoxanthine (5mM), aminopterin (20μM) and thymidine (0.8mM)
- Hypoxanthine and thymidine supply preformed purines and pyrimidines for DNA synthesis by hybridomas via the salvage pathway that utilizes HGPRT contributed by the fused spleen cell
- Aminopterin, a folic acid antagonist, inhibits the de novo nucleoside biosynthesis pathway
Cell Culture, Mammalian Cell Culture
Order Info
Shipping Condition: Dry Ice

Specifications
Storage conditions: -5 to -20°C Shipping conditions: Dry ice Shelf life: 14 months from date of manufacture |
|
50 X | |
HT Supplement | |
6 to 8 | |
Dry Ice |
Mammalian Cells | |
Liquid | |
Sterile-filtered | |
100 mL |
Certificates
A lot number is required to show results for certificates. To find your lot number on previous orders use our order status area.
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
2579468 | Certificate of Analysis | 29/01/2025 | 21060017 |
2773613 | Certificate of Analysis | 28/01/2025 | 21060017 |
2843106 | Certificate of Analysis | 27/01/2025 | 21060017 |
2931596 | Certificate of Analysis | 26/01/2025 | 21060017 |
3023612 | Certificate of Analysis | 25/01/2025 | 21060017 |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
For Research Use Only. Not for use in diagnostic procedures.